Cargando…
Use of carefully titrated ultra‐low doses of alteplase in infected haemothorax caused by initial alteplase use to drain loculated malignant pleural effusion
Alteplase as a fibrinolytic can be used to break up fibrin to encourage clot breakdown for clinical use. In the pleural space, it is used for symptomatic loculated malignant pleural effusions and pleural infections and can potentially avoid the need for surgical intervention. The optimal dose and do...
Autores principales: | Oh, Jeong Suk, Yoo, Chris, Wong, Donny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412854/ https://www.ncbi.nlm.nih.gov/pubmed/37577412 http://dx.doi.org/10.1002/rcr2.1202 |
Ejemplares similares
-
USE OF ALTEPLASE AND DORNASE FOR LYSIS OF COVID-19-RELATED LOCULATED PLEURAL EFFUSION
por: STAIANO, PETER P, et al.
Publicado: (2022) -
Intrapleural Fibrinolytic Therapy With Alteplase for the Management of Multiloculated Malignant Pleural Effusion: A Case Series
por: Nemet, Marko, et al.
Publicado: (2022) -
Intrapleural hemorrhage due to alteplase use in a 6-year-old boy with pleural effusion
por: Hendaus, Mohamed A, et al.
Publicado: (2013) -
Retrospective review comparing intrapleural fibrinolytic therapy (alteplase) and surgical intervention in complex pleural effusion
por: Abdul Hamid, Mohamed Faisal, et al.
Publicado: (2022) -
Chronic haemothorax: an important cause of pleural effusion
por: Ching, David K. Z., et al.
Publicado: (2021)